Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2023-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$81.7m reported value +36.6% vs Q1 2023

26positions

81.9%in top 10

2 new 2 added 0 reduced 0 sold out vs Q1 2023

Options: 1 call positions ($814.3k notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	ALDEYRA THERAPEUTICS INC COM ALDX	ALDX	3,015,668	$25.3m30.98%	30.98%	Added +948.5k	+948,508 45.9%
2	BIOHAVEN PHARMACTL HLDG CO L COM BHVN	BHVN	450,422	$10.8m13.19%	13.19%	Unchanged
3	AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR		500,000	$8.2m10.09%	10.09%	New
4	HOOKIPA PHARMA INC COM COM		5,517,385	$4.9m5.94%	5.94%	Added +5.2m	+5,217,385 1739.1%
5	APPLIED THERAPEUTICS INC COM APLT	APLT	3,450,000	$4.4m5.41%	5.41%	Unchanged
6	VERONA PHARMA PLC SPONSORED ADS VRNA	VRNA	200,000	$4.2m5.18%	5.18%	Unchanged
7	VANECK ETF TRUST GOLD MINERS ETF GDX	GDX	91,850	$2.8m3.39%	3.39%	Unchanged
8	GLOBAL X FDS GLOBAL X SILVER SIL	SIL	89,700	$2.3m2.85%	2.85%	Unchanged
9	ENTERA BIO LTD SHS ENTX	ENTX	2,484,275	$2.1m2.56%	2.56%	Unchanged
10	VANECK ETF TRUST JUNIOR GOLD MINE GDXJ	GDXJ	53,150	$1.9m2.32%	2.32%	Unchanged
11	BOOZ ALLEN HAMILTON HLDG COR CL A BAH	BAH	13,000	$1.5m1.78%	1.78%	Unchanged
12	VISA INC COM CL A V	V	4,850	$1.2m1.41%	1.41%	Unchanged
13	THERMO FISHER SCIENTIFIC INC COM TMO	TMO	2,100	$1.1m1.34%	1.34%	Unchanged
14	OCULAR THERAPEUTIX INC COM OCUL	OCUL	200,000	$1.0m1.26%	1.26%	Unchanged
15	ALTRIA GROUP INC COM MO	MO	22,700	$1.0m1.26%	1.26%	Unchanged
16	CVS HEALTH CORP COM CVS	CVS	14,500	$1.0m1.23%	1.23%	Unchanged
17	FRANCO NEV CORP COM FNV	FNV	7,000	$998.2k1.22%	1.22%	Unchanged
18	SILVERCREST METALS INC COM SIL	SIL	170,000	$996.2k1.22%	1.22%	Unchanged
19	NORTHROP GRUMMAN CORP COM NOC	NOC	2,165	$986.8k1.21%	1.21%	Unchanged
20	OSISKO GOLD ROYALTIES LTD COM COM		400,000	$969.2k1.19%	1.19%	Unchanged
21	OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK		173,010	$968.9k1.19%	1.19%	Unchanged
22	SEABRIDGE GOLD INC COM COM		80,000	$964.0k1.18%	1.18%	Unchanged
23	Orgenesis, Inc. COM COM		634,738	$882.3k1.08%	1.08%	Unchanged
24	ALTIMMUNE INC COM NEW ALT	ALT	173,864	$613.7k0.75%	0.75%	Unchanged
25	OPUS GENETICS INC COM IRD	IRD	100,000	$434.0k0.53%	0.53%	Unchanged
26	BIOXCEL THERAPEUTICS INC COM COM		30,000	$199.8k0.24%	0.24%	New

Options (notional value)

Underlying	Ticker	Type	Shares controlled	Notional	Change
OCULAR THERAPEUTIX INC OCUL · Call	OCUL	Call	95,800	$814.3k95.8k shares	Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08	ELTX	5.3%≈ $4.7m	+0.1 pts	13G	2026-07-08